Rates also notable: US jobs report due this morning
The US October employment report is due at 8:30 AM Eastern today, Banxico's surprise cut to 6.25 percent takes effect today, and the Treasury's $4 billion front end buyback settles today.
Every story, newest first.
The US October employment report is due at 8:30 AM Eastern today, Banxico's surprise cut to 6.25 percent takes effect today, and the Treasury's $4 billion front end buyback settles today.
Princeton Digital Group secured about 1.3 billion dollars (5.1 billion ringgit) of green financing from six banks for its 200 megawatt JH1 data centre campus in Johor, Malaysia.
Portugal is finalising legislation that would require data centers to run on renewable energy and to use waterless cooling or water sources that do not compete with household and business supplies.
Scalise and Jordan formalised their rival bids to lead House Republicans in letters built around resisting Democratic investigations, while a Republican move to impeach Defense Secretary Hegseth is set for a lame duck vote next week.
Philippine headline inflation accelerated to 7.8 percent in October from 7.2 percent in September, the fastest pace since February 2023, as transport costs rose 20.1 percent on the year.
Perpetua Resources reported a new Fiddle discovery at Stibnite, with a first hole returning 109.7 metres grading 3.2 grams per tonne gold and 1.1 percent antimony.
The Office of Strategic Capital signed conditional loan commitments of 250 million dollars with 6K Inc. and 75 million dollars with Halo Industries, each designed to crowd in an equal amount of private capital.
Triple Flag kept its raised 2026 sales guidance, Phoenix Tailings lined up $54.2 million in incentives for its Rochester rare earth plant, Labrador Gold opened a strategic review, and Gem Resources changed chief executive.
The MHRA on November 5 issued interim monitoring advice for Duvyzat (givinostat) after several deaths were reported internationally in Duchenne muscular dystrophy patients taking the drug, with no deaths reported in the United Kingdom.
The MHRA on November 5 published a Class 4 defect notification for Sandoz co-amoxiclav suspension, whose dosing table instructed about twice the intended dose, and a Class 3 recall of three Aspire tropicamide eye drop batches with the wrong expiry date printed.